These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 30803999)
41. Reduction of functional N-methyl-D-aspartate receptors in neurons by RNase P-mediated cleavage of the NR1 mRNA. Yen L; Gonzalez-Zulueta M; Feldman A; Yuan Y; Fryer H; Dawson T; Dawson V; Kalb RG J Neurochem; 2001 Mar; 76(5):1386-94. PubMed ID: 11238723 [TBL] [Abstract][Full Text] [Related]
42. Developing RNase P ribozymes for gene-targeting and antiviral therapy. Trang P; Kim K; Liu F Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592 [TBL] [Abstract][Full Text] [Related]
43. Short oligonucleotides as external guide sequences for site-specific cleavage of RNA molecules with human RNase P. Werner M; Rosa E; Nordstrom JL; Goldberg AR; George ST RNA; 1998 Jul; 4(7):847-55. PubMed ID: 9671057 [TBL] [Abstract][Full Text] [Related]
44. Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences. Lundblad EW; Xiao G; Ko JH; Altman S Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2354-7. PubMed ID: 18263737 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of no tail (ntl) gene expression in zebrafish by external guide sequence (EGS) technique. Pei DS; Sun YH; Long Y; Zhu ZY Mol Biol Rep; 2008 Jun; 35(2):139-43. PubMed ID: 17294249 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of viral gene expression by human ribonuclease P. Kawa D; Wang J; Yuan Y; Liu F RNA; 1998 Nov; 4(11):1397-406. PubMed ID: 9814760 [TBL] [Abstract][Full Text] [Related]
47. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Ma M; Benimetskaya L; Lebedeva I; Dignam J; Takle G; Stein CA Nat Biotechnol; 2000 Jan; 18(1):58-61. PubMed ID: 10625392 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant. Sun X; Chen W; He L; Sheng J; Liu Y; Vu GP; Yang Z; Li W; Trang P; Wang Y; Hai R; Zhu H; Lu S; Liu F PLoS One; 2017; 12(10):e0186791. PubMed ID: 29059242 [TBL] [Abstract][Full Text] [Related]
49. RNA cleavage by a mammalian tRNA 3'processing endoribonuclease (3'tRNase) reduces HIV-1 expression. Yukita M; Kitano M; Miyano-Kurosaki N; Takeuchi H; Nashimoto M; Takaku H Nucleic Acids Res Suppl; 2002; (2):297-8. PubMed ID: 12903222 [TBL] [Abstract][Full Text] [Related]
50. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals. Li W; Liu Y; Wang Y; Li R; Trang P; Tang W; Yang Z; Wang Y; Sun X; Xing X; Lu S; Liu F Theranostics; 2018; 8(20):5634-5644. PubMed ID: 30555569 [No Abstract] [Full Text] [Related]
51. A viral RNA motif involved in signaling the initiation of translation on non-AUG codons. Sanz MA; Almela EG; García-Moreno M; Marina AI; Carrasco L RNA; 2019 Apr; 25(4):431-452. PubMed ID: 30659060 [TBL] [Abstract][Full Text] [Related]
52. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889 [TBL] [Abstract][Full Text] [Related]
53. Evidence for recycling of external guide sequences during cleavage of bipartite substrates in vitro by reconstituted archaeal RNase P. Cho IM; Kazakov SA; Gopalan V J Mol Biol; 2011 Feb; 405(5):1121-7. PubMed ID: 21144851 [TBL] [Abstract][Full Text] [Related]
54. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus]. Zhang W; Li X; Luo G; Huang Z; Liu Y Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280 [TBL] [Abstract][Full Text] [Related]
55. Engineering of RNase P ribozyme for gene-targeting applications. Raj SM; Liu F Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377 [TBL] [Abstract][Full Text] [Related]
56. Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Kraus G; Geffin R; Spruill G; Young AK; Seivright R; Cardona D; Burzawa J; Hnatyszyn HJ Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3406-11. PubMed ID: 11904403 [TBL] [Abstract][Full Text] [Related]
57. External guide sequence technology: a path to development of novel antimicrobial therapeutics. Davies-Sala C; Soler-Bistué A; Bonomo RA; Zorreguieta A; Tolmasky ME Ann N Y Acad Sci; 2015 Sep; 1354(1):98-110. PubMed ID: 25866265 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of the expression of the human RNase P protein subunits Rpp21, Rpp25, Rpp29 by external guide sequences (EGSs) and siRNA. Zhang H; Altman S J Mol Biol; 2004 Sep; 342(4):1077-83. PubMed ID: 15351636 [TBL] [Abstract][Full Text] [Related]
59. Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme. Zeng W; Chen YC; Bai Y; Trang P; Vu GP; Lu S; Wu J; Liu F PLoS One; 2012; 7(12):e51855. PubMed ID: 23300569 [TBL] [Abstract][Full Text] [Related]
60. Suppression of HIV-1 replication by a combination of endonucleolytic ribozymes (RNase P and tRNnase ZL). Ikeda M; Habu Y; Miyano-Kurosaki N; Takaku H Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):427-37. PubMed ID: 16838836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]